Litcius/Paper detail

First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment

Rosa Bellavita, Bruno Casciaro, Salvatore Di Maro, Diego Brancaccio, Alfonso Carotenuto, Annarita Falanga, Floriana Cappiello, Elisabetta Buommino, Stefania Galdiero, Ettore Novellino, Tom N. Grossmann, Maria Luisa Mangoni, Francesco Merlino, Paolo Grieco

2021Journal of Medicinal Chemistry40 citationsDOIOpen Access PDF

Abstract

The pharmacodynamic and pharmacokinetic properties of bioactive peptides can be modulated by introducing conformational constraints such as intramolecular macrocyclizations, which can involve either the backbone and/or side chains. Herein, we aimed at increasing the α-helicity content of temporin L, an isoform of an intriguing class of linear antimicrobial peptides (AMPs), endowed with a wide antimicrobial spectrum, by the employment of diverse side-chain tethering strategies, including lactam, 1,4-substituted [1,2,3]-triazole, hydrocarbon, and disulfide linkers. Our approach resulted in a library of cyclic temporin L analogues that were biologically assessed for their antimicrobial, cytotoxic, and antibiofilm activities, leading to the development of the first-in-class cyclic peptide related to this AMP family. Our results allowed us to expand the knowledge regarding the relationship between the α-helical character of temporin derivatives and their biological activity, paving the way for the development of improved antibiotic cyclic AMP analogues.

Topics & Concepts

ChemistryAntimicrobialAntimicrobial peptidesCyclic peptideCombinatorial chemistrySide chainLinkerPeptideDisulfide bondIntramolecular forceStereochemistryLactamBiological activityBiochemistryIn vitroOrganic chemistryPolymerOperating systemComputer scienceAntimicrobial Peptides and ActivitiesChemical Synthesis and AnalysisBiochemical and Structural Characterization
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment | Litcius